![Mark Carlton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Mark Carlton
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Director Técnico/Científico/I+D | 01/01/2016 | - |
Fundador | 01/01/2016 | - |
Historial de carrera de Mark Carlton
Antiguos cargos conocidos de Mark Carlton.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Director/Miembro de la Junta | 01/01/1999 | 12/03/2007 |
Director Técnico/Científico/I+D | 01/01/1999 | 12/03/2007 |
Formación de Mark Carlton.
University of Cambridge | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 3 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Carlton
- Experiencia